PRA Health Sciences — Q3 2016 Earnings Presentation
17 slides from PRA Health Sciences's earnings presentation, Nov 2, 2016
Slide 1: Q3 2016 Earnings
Q3 2016 Earnings November 2, 2016
Slide 2: Forward Looking Statements and Use of Non-GAAP Financial Measures
Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains forward-looking statements that reflect, among other things, the Company’s current expectations and anticipated results of operations, all of which are subject to known and unknown risks, uncertainties and o
Slide 3: Q3 2016 Highlights
Q3 2016 Highlights ($ in millions, except per share amounts) $399.8 million of service revenue; 16.0% constant currency growth $31.4 million of GAAP Net Income; 32.9% growth compared to prior year $74.7 million of Adjusted EBITDA; 12.2% growth compared to prior year Adjusted Net Income per diluted s
Slide 4: Trailing Quarterly Performance
Trailing Quarterly Performance Adjusted Income from Operations ($M) Adjusted EBITDA Margin (%) Service Revenue ($M) Adjusted EBITDA ($M) $41.0 $45.2 $50.6 $56.2 $61.2 $62.4 $61.7 $67.4 $68.3 Q3 2014 Q4 2014 Q1 2015 Q2 2015 Q3 2015 Q4 2015 Q1 2016 Q2 2016 Q3 2016 14.7% 15.6% 16.8% 18.2% 19.3% 18.8% 1
Slide 5: Backlog and New Business Awards
Backlog and New Business Awards Ending Backlog ($M) Backlog Conversion % Net Book-to-Bill Net New Business Awards ($M) 1.19 1.20 1.20 1.21 1.25 1.27 1.28 1.25 1.30 Q3 2014 Q4 2014 Q1 2015 Q2 2015 Q3 2015 Q4 2015 Q1 2016 Q2 2016 Q3 2016 $382.1 $388.4 $398.0 $407.8 $431.4 $459.4 $476.2 $493.9 $519.1 Q
Slide 6: Debt Structure
Debt Structure Weighted Average ($ in millions) September 30, December 31, March 31, June 30, September 30, Interest Maturity 2015 2015 2016 2016 2016 Rate Date Senior debt: First Lien 689.0 $ 689.0 $ 689.0 $ 689.0 $ 689.0 $ 4.50% September 23, 2020 Senior Notes 225.0 225.0 91.4 91.4 91.4 9.50% Octo
Slide 7: 2016 Guidance Update
2016 Guidance Update Original Guidance (Feb 24, 2016) Revised Guidance (April 27, 2016) Revised Guidance (Nov 2, 2016) Service Revenue, in Millions $1,530.0 – $1,570.0 $1,530.0 – $1,570.0 $1,568.0 – $1,573.0 GAAP Earnings per Diluted Share $1.56 – $1.66 $1.08 – $1.15 $1.30 – $1.33 Adjusted Net Incom
Slide 8: Appendix
Appendix RAHEALTHSCIENCES
Slide 9: Q3 and YTD 2016 Financial Results
Q3 and YTD 2016 Financial Results ($ in millions) 2016 2015 % Change 2016 2015 % Change Service Revenue 399.8 $ 345.1 $ 15.9% 1,166.4 $ 1,013.6 $ 15.1% EBITDA 73.8 $ 69.4 $ 6.3% 166.8 $ 181.9 $ -8.3% Adjusted EBITDA 74.7 $ 66.6 $ 12.2% 215.4 $ 183.7 $ 17.3% Adjusted EBITDA Margin 18.7% 19.3% 18.5% 1
Slide 10: Trailing Quarterly Performance
Trailing Quarterly Performance Q3 16 v ($ in millions) Q3 15 % Q3 Q4 FY Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Change Service Revenue 320.1 $ 323.8 $ 1,266.6 $ 332.0 $ 336.5 $ 345.1 $ 362.3 $ 1,375.8 $ 372.3 $ 394.2 $ 399.8 $ 15.9% % growth Y-o-Y 70.2% 8.4% 52.1% 6.6% 8.1% 7.8% 11.9% 8.6% 12.2% 17.2% 15.9% % growt
Slide 11: Backlog and New Business Awards
Backlog and New Business Awards Q3 16 v ($ in millions) Q3 15 % Q3 Q4 FY Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Change Beginning Backlog 2,044.8 $ 2,091.5 $ 1,939.7 $ 2,141.1 $ 2,185.3 $ 2,262.4 $ 2,348.4 $ 2,141.1 $ 2,440.1 $ 2,552.8 $ 2,649.4 $ Ending Backlog 2,091.5 $ 2,141.1 $ 2,141.1 $ 2,185.3 $ 2,262.4 $ 2,3
Slide 12: Reconciliation of GAAP Net Income to Adjusted EBITDA
Reconciliation of GAAP Net Income to Adjusted EBITDA For further information regarding the reconciliation of non-GAAP measures to their corresponding GAAP equivalent please see our press release ($ in millions) 2016 2015 2016 2015 Net income 31.4 $ 23.7 $ 54.2 $ 53.3 $ Depreciation and amortization
Slide 13: Reconciliation of GAAP Net Income to Adjusted Net Income
Reconciliation of GAAP Net Income to Adjusted Net Income For further information regarding the reconciliation of non-GAAP measures to their corresponding GAAP equivalent please see our press release ($ in millions, except per share data) 2016 2015 2016 2015 Net income 31.4 $ 23.7 $ 54.2 $ 53.3 $ Amo
Slide 14: Reconciliation of GAAP Income from Operations to Adjusted Income from Operations
Reconciliation of GAAP Income from Operations to Adjusted Income from Operations For further information regarding the reconciliation of non-GAAP measures to their corresponding GAAP equivalent please see our press release ($ in millions) 2016 2015 2016 2015 Income from operations 54.8 $ 49.2 $ 124.
Slide 15: Geographic Breakdown
Geographic Breakdown ($ in millions) Region Q3 16 Q3 15 US/Canada 238.1 208.1 Europe/Africa 123.0 104.1 Latin America 16.5 14.1 Asia/Pacific 22.3 18.8 Grand Total 399.8 345.1 Region YTD 2016 YTD 2015 US/Canada 703.6 615.9 Europe/Africa 355.6 304.3 Latin America 46.3 41.4 Asia/Pacific 60.9 52.1 Grand
Slide 16: Days Sales Outstanding
Days Sales Outstanding ($ in millions) Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Accounts Receivable, net 236.1 $ 233.3 $ 239.6 $ 281.4 $ 281.9 $ 288.3 $ 285.7 $ 320.6 $ 310.5 $ Unbilled Services 113.2 105.5 132.8 115.2 118.5 126.8 134.4 142.8 136.6 Total Accounts Receivable and Unbilled Services 349.3 338.8 372.4
Slide 17: PRA Health Sciences
m\/A Ws PRAHEALTHSCIENCES HE FU RE OF CLINICAL DEVELOPME